Suppr超能文献

可变剪接是 hTERT 表达的发育开关。

Alternative splicing is a developmental switch for hTERT expression.

机构信息

Skirball Institute of Biomolecular Medicine, Department of Cell Biology, NYU School of Medicine, New York, NY 10016, USA.

Institute for Systems Genetics and Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY 10016, USA.

出版信息

Mol Cell. 2021 Jun 3;81(11):2349-2360.e6. doi: 10.1016/j.molcel.2021.03.033. Epub 2021 Apr 13.

Abstract

Telomere length control is critical for cellular lifespan and tumor suppression. Telomerase is transiently activated in the inner cell mass of the developing blastocyst to reset telomere reserves. Its silencing upon differentiation leads to gradual telomere shortening in somatic cells. Here, we report that transcriptional regulation through cis-regulatory elements only partially accounts for telomerase activation in pluripotent cells. Instead, developmental control of telomerase is primarily driven by an alternative splicing event, centered around hTERT exon 2. Skipping of exon 2 triggers hTERT mRNA decay in differentiated cells, and conversely, its retention promotes telomerase accumulation in pluripotent cells. We identify SON as a regulator of exon 2 alternative splicing and report a patient carrying a SON mutation and suffering from insufficient telomerase and short telomeres. In summary, our study highlights a critical role for hTERT alternative splicing in the developmental regulation of telomerase and implicates defective splicing in telomere biology disorders.

摘要

端粒长度的控制对细胞寿命和肿瘤抑制至关重要。端粒酶在发育中的囊胚内细胞团中短暂激活,以重置端粒储备。在分化过程中端粒酶的沉默导致体细胞中端粒逐渐缩短。在这里,我们报告说,通过顺式调控元件的转录调控仅部分解释了多能细胞中端粒酶的激活。相反,端粒酶的发育控制主要由一个围绕 hTERT 外显子 2 的剪接事件驱动。外显子 2 的跳过触发分化细胞中 hTERT mRNA 的降解,相反,其保留促进了多能细胞中端粒酶的积累。我们确定 SON 是外显子 2 剪接的调节剂,并报告了一名携带 SON 突变并患有端粒酶不足和端粒短的患者。总之,我们的研究强调了 hTERT 剪接在端粒酶发育调控中的关键作用,并暗示剪接缺陷与端粒生物学紊乱有关。

相似文献

1
Alternative splicing is a developmental switch for hTERT expression.可变剪接是 hTERT 表达的发育开关。
Mol Cell. 2021 Jun 3;81(11):2349-2360.e6. doi: 10.1016/j.molcel.2021.03.033. Epub 2021 Apr 13.

引用本文的文献

4
Telomerase-Mediated Anti-Ageing Interventions.端粒酶介导的抗衰老干预措施。
Subcell Biochem. 2024;107:1-20. doi: 10.1007/978-3-031-66768-8_1.
6
Telomeres and telomerase in Sarcoma disease and therapy.肉瘤疾病与治疗中的端粒和端粒酶。
Int J Med Sci. 2024 Aug 6;21(11):2065-2080. doi: 10.7150/ijms.97485. eCollection 2024.
7
Strategic targeting of Cas9 nickase induces large segmental duplications.Cas9 核酸酶的靶向性诱导大片段重复。
Cell Genom. 2024 Aug 14;4(8):100610. doi: 10.1016/j.xgen.2024.100610. Epub 2024 Jul 24.

本文引用的文献

1
Regulation of human telomerase in homeostasis and disease.人类端粒酶在体内平衡和疾病中的调控。
Nat Rev Mol Cell Biol. 2020 Jul;21(7):384-397. doi: 10.1038/s41580-020-0234-z. Epub 2020 Apr 2.
3
Revisiting Telomere Shortening in Cancer.重新审视癌症中的端粒缩短。
Cells. 2019 Jan 31;8(2):107. doi: 10.3390/cells8020107.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验